Delray Beach, FL, Feb. 16, 2026 (GLOBE NEWSWIRE) -- Strategic investments in ASO and siRNA platforms, coupled with breakthrough delivery technologies, position oligonucleotide therapeutics as ...
(MENAFN- GetNews) Oligonucleotide Therapeutics Market by Molecule (Nusinersen, Vutrisiran, Inclisiran, Eteplisiran), Type (ASO, siRNA, Others), Disease Type ...
The MarketWatch News Department was not involved in the creation of this content. SAN CARLOS, Calif., Jan. 6, 2026 /PRNewswire/ -- Aperture Therapeutics, a biotechnology company pioneering ...
The application of polymeric materials in this context relies on the ability of polycations to electrostatically associate with anionic oligonucleotides in aqueous environments, forming nano complexes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results